Learn more about Peter Attia’s digital program
#286 ‒ Journal club with Andrew Huberman: the impact of light exposure on mental health and an immunotherapy breakthrough for cancer treatment
“People spend 90% of their time indoors now. Their daytime environments are too dim, their nighttime environments are too bright.” —Andrew Huberman
Antitumor mRNA vaccines are cause for optimism
Moderna recently announced preliminary results of a clinical trial involving a personalized antitumor mRNA vaccine, and despite the knee-jerk uproar, the treatment may prove to be another useful weapon in the battle against cancer
#177 – Steven Rosenberg, M.D., Ph.D.: The development of cancer immunotherapy and its promise for treating advanced cancers
“It’s the balance of the aggressive immune reaction against the inhibitory molecules that can prevent that immune reaction that is the holy grail of trying to find effective treatments.” —Steven Rosenberg
#121 – Azra Raza, M.D.: Why we’re losing the war on cancer
“We are living in an era of the most sophisticated technological advances possible, and yet the treatment of cancer is paleolithic.” — Azra Raza
#62 – Keith Flaherty, M.D.: Deep dive into cancer— History of oncology, novel approaches to treatment, and the exciting and hopeful future
“We can’t keep hitting the same pillar and expect that we’re going to cure cancer. . .we need the activators of the immune system, we need the inhibitors of the activated oncogenes, we need the drugs that target epigenetic regulators, and we need the metabolic switch regulators.” — Keith Flaherty